HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RFamide peptides 43RFa and 26RFa both promote survival of pancreatic β-cells and human pancreatic islets but exert opposite effects on insulin secretion.

Abstract
RFamide peptides 43RFa and 26RFa have been shown to promote food intake and to exert different peripheral actions through G-protein-coupled receptor 103 (GPR103) binding. Moreover, 26RFa was found to inhibit pancreatic insulin secretion, whereas the role of 43RFa on β-cell function is unknown, as well as the effects of both peptides on β-cell survival. Herein, we investigated the effects of 43RFa and 26RFa on survival and apoptosis of pancreatic β-cells and human pancreatic islets. In addition, we explored the role of these peptides on insulin secretion and the underlying signaling mechanisms. Our results show that in INS-1E β-cells and human pancreatic islets both 43RFa and 26RFa prevented cell death and apoptosis induced by serum starvation, cytokine synergism, and glucolipotoxicity, through phosphatidylinositol 3-kinase/Akt- and extracellular signal-related kinase 1/2-mediated signaling. Moreover, 43RFa promoted, whereas 26RFa inhibited, glucose- and exendin-4-induced insulin secretion, through Gαs and Gαi/o proteins, respectively. Inhibition of GPR103 expression by small interfering RNA blocked 43RFa insulinotropic effect, but not the insulinostatic action of 26RFa. Finally, 43RFa, but not 26RFa, induced cAMP increase and glucose uptake. In conclusion, because of their survival effects along with the effects on insulin secretion, these findings suggest potential for 43RFa and 26RFa as therapeutic targets in the treatment of diabetes.
AuthorsRiccarda Granata, Fabio Settanni, Letizia Trovato, Davide Gallo, Iacopo Gesmundo, Rita Nano, Maria Pia Gallo, Loredana Bergandi, Marco Volante, Giuseppe Alloatti, Lorenzo Piemonti, Jérôme Leprince, Mauro Papotti, Hubert Vaudry, Huy Ong, Ezio Ghigo
JournalDiabetes (Diabetes) Vol. 63 Issue 7 Pg. 2380-93 (Jul 2014) ISSN: 1939-327X [Electronic] United States
PMID24622796 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 by the American Diabetes Association.
Chemical References
  • 43RFa peptide, human
  • Insulin
  • Intercellular Signaling Peptides and Proteins
  • Neuropeptides
  • Peptides
  • QRFP peptide
  • QRFPR protein, human
  • RFamide peptide
  • Receptors, G-Protein-Coupled
  • prepro-26RFa protein, human
Topics
  • Animals
  • Apoptosis (drug effects)
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Humans
  • Insulin (metabolism)
  • Insulin Secretion
  • Insulin-Secreting Cells (drug effects, physiology)
  • Intercellular Signaling Peptides and Proteins
  • Islets of Langerhans (drug effects, physiology)
  • Neuropeptides (pharmacology)
  • Peptides (genetics, metabolism)
  • Rats
  • Receptors, G-Protein-Coupled (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: